Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Artizan Biosciences

Request full access

Pioneering precision therapeutics that neutralize microbial triggers to restore intestinal health to treat diseases

New Haven, United StatesFounded 2016Biotech & Life Sciences

About Artizan Biosciences

Artizan Biosciences, Inc. is a biotechnology company focused on developing microbiome-based therapies to treat chronic diseases. The company leverages cutting-edge research from Yale Immunobiology faculty members to create precision medicine solutions that target the root causes of various chronic conditions. Artizan Biosciences operates in the biopharmaceutical market, primarily serving healthcare providers and patients who suffer from chronic diseases. The business model revolves around research and development, clinical trials, and eventual commercialization of its proprietary therapies. Revenue is generated through partnerships, grants, and future sales of approved treatments. The company aims to revolutionize the treatment landscape by offering targeted, effective, and personalized medical solutions.

Source: Dealroom company data

At a glance

Status
Operational
Employees
3
Open positions
None listed
Dealroom signal
63.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Marketplace & ecommerce
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jun 2022 $19M $76M Undisclosed ↗
SERIES A✓Equity / VC Mar 2021 $11M $60M Connecticut Innovations · Elm Street Ventures · Osage University Partners · Biohaven —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Artizan Biosciences website traffic

Latest recorded traffic for Artizan Biosciences is 220 monthly website visits, down 99.5% over the last three months. Artizan Biosciences's team grew 0% over the past year.

Latest monthly visits220 3-month web change-99.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Artizan Biosciences in the New Haven ecosystem

Live from Dealroom

The Artizan Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Connecticut Innovations
  • Elm Street Ventures
  • Osage University Partners
  • Biohaven
  • Hatteras Venture Partners

Other known investors2 additional known investors

  • Yale University
  • Yale Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Artizan Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Artizan Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.